Inhibition of cholesterol synthesis by ketoconazole

The American Journal of Medicine
F B Kraemer, A Pont

Abstract

To determine if ketoconazole influences cholesterol metabolism in humans, plasma lipid levels were studied in seven men with advanced prostate cancer who were being treated with high-dose ketoconazole. Additionally, the effects of ketoconazole on cholesterol synthesis in cultured normal human fibroblasts were studied. High-dose ketoconazole therapy caused a 27 percent reduction in total serum cholesterol values without affecting serum triglyceride levels. The reduction in serum cholesterol levels was maintained for five months in six of seven patients. The fall in total cholesterol levels was due to a 38 percent reduction in low-density lipoprotein cholesterol levels without associated changes in high-density lipoprotein cholesterol levels. Serum lanosterol levels increased 46 percent during ketoconazole treatment. Studies in cultured normal human fibroblasts showed that ketoconazole inhibited cholesterol synthesis by blocking the conversion of lanosterol to cholesterol. These results establish that ketoconazole is a potent inhibitor of cholesterol production in vivo and in vitro.

References

Sep 1, 1979·Postgraduate Medical Journal·D BorelliD A Stevens
May 1, 1976·Analytical Chemistry·J J Kabara, J S Chen
Jan 1, 1971·Annals of Internal Medicine·W B KannelP M McNamara
Aug 25, 1984·Lancet·J Trachtenberg, A Pont
Dec 1, 1984·Lancet·T A Miettinen, V V Valtonen
Jun 1, 1980·Antimicrobial Agents and Chemotherapy·H Van den BosscheJ M van Cutsem
Jan 1, 1982·Antimicrobial Agents and Chemotherapy·C BrassD A Stevens
Sep 1, 1982·Annals of Internal Medicine·A PontD A Stevens
Nov 1, 1982·Archives of Internal Medicine·A PontD A Stevens
May 1, 1983·The Journal of Clinical Investigation·D S LooseD Feldman
Jul 1, 1983·The Journal of Urology·J TrachtenbergA Pont
Oct 1, 1983·The Journal of Clinical Endocrinology and Metabolism·R J SantenR DeCoster
Oct 1, 1983·Antimicrobial Agents and Chemotherapy·T M Buttke, S W Chapman
Mar 1, 1982·The Medical Clinics of North America·R M Krauss
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON
Nov 1, 1959·Archives of Biochemistry and Biophysics·T R BLOHM, R D MACKENZIE
May 1, 1961·The Journal of Clinical Investigation·D SteinbergE B Feigelson

❮ Previous
Next ❯

Citations

Jan 1, 1991·Cancer Chemotherapy and Pharmacology·S NaftalovichY Eilam
Mar 1, 1989·Archives of Gerontology and Geriatrics·L BalducciC Hardy
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·V JolyP Yeni
Jul 8, 2005·Applied and Environmental Microbiology·Hassan HajjajLaurent B Fay
Sep 9, 2008·Mayo Clinic Proceedings·Michail S LionakisDimitrios P Kontoyiannis
May 5, 2004·The Urologic Clinics of North America·Mark A Moyad, Markus Sonnleithner
Jun 1, 1989·British Journal of Clinical Pharmacology·M H DevenportL J Lees
Jul 1, 1989·Clinics in Dermatology·H F Merk, H Mukhtar
Sep 24, 1987·The New England Journal of Medicine·N Sonino
Aug 1, 1986·Journal of Endocrinological Investigation·N Sonino
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Wiam I HusseinByron J Hoogwerf
Aug 4, 2020·The Keio Journal of Medicine·Hideaki NagashimaOltea Sampetrean

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.